Report Store Get Proposal

Home Blog Tag Sitc 2024

SITC 2024

trop2-inhibitors-for-cancer-treatment

Nov 19, 2024

SITC 2024 Summary: Quick Recap of what all happened during this year’s annual meeting

The Society for Immunotherapy of Cancer i.e., SITC 2024 conference provided a comprehensive view into the latest innovations in cancer immunotherapy, including data on CAR T-cell therapies, cancer vaccines, bispecific and multispecific antibodies, along with next-generation cancer vaccines. Presentations from vario...

Read More...

A New Era for Multiple Myeloma Treatment: Bispecific Antibodies Enter the Fray

Articles

Jun 10, 2025

ADCs in Lung Cancer Treatment: ENHERTU’s Rise, HER3 & TROP-2 Challenges, and What’s Next in the Pipeline

Articles

May 09, 2025

LEQEMBI: A New Hope for Alzheimer’s Disease Patients

Articles

Feb 12, 2025

Unleashing the Potential: CD38 Directed Therapies Revolutionize Multiple Myeloma Treatment

Articles

Sep 24, 2024

Toll-like Receptors Agonist

TLR 7 and 8 Agonist

Gene Therapies Whitepaper

Toll-like Receptors Agonist

TLR 7 and 8 Agonist

Gene Therapies Whitepaper

Newsletter/Whitepaper